Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients-Reference-Cited by-同舟云学术

Aquaretic Effect of Lixivaptan, an Oral, Non-Peptide, Selective V2 Receptor Vasopressin Antagonist, in New York Heart Association Functional Class II and III Chronic Heart Failure Patients

Published:2006-04 Issue:8 Volume:47 Page:1615-1621
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Abraham William T.,Shamshirsaz Alireza A.,McFann Kim,Oren Ron M.,Schrier Robert W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Renal salt and water handling in congestive heart failure;Abraham,2000

2. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure;Lee;Circulation,1986

3. Predicting mortality among patients hospitalized for heart failure;Lee;JAMA,2003

4. Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion;Anderson;J Clin Invest,1974

5. Arginine vasopressin gene expression in chronic cardiac failure in rats;Kim;Kidney Int,1990

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasopressin: a possible link between hypoxia and hypertension;Exploration of Medicine;2022-10-11

2. Challenges in diuretic therapy: A case-based discussion;The American Journal of the Medical Sciences;2022-10

3. Pathophysiology of heart failure and an overview of therapies;Cardiovascular Pathology;2022

4. Updates and Perspectives on Aquaporin-2 and Water Balance Disorders;International Journal of Molecular Sciences;2021-11-30

5. Vasopressin Type 2 Receptor Agonists and Antagonists;Reference Module in Biomedical Sciences;2021